Here, the authors show that hepatic WTAP is a key integrative repressor of ectopic lipid accumulation and inflammation during NASH progression, and hepatic deletion of Wtap promotes both of them, leading to NASH. The gene discussed is WTAP; the disease is metabolic dysfunction-associated steatohepatitis.